Which estrogen treatment do women prefer to prevent recurrent UTIs?
NCT ID NCT05723601
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two forms of vaginal estrogen—cream and tablet—to see which one post-menopausal women prefer for preventing recurrent urinary tract infections (UTIs). About 21 women who have had multiple UTIs will try both treatments and then choose their favorite. The goal is to find a treatment that women are more likely to use consistently, which could help prevent future infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT URINARY TRACT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New symptom diaries aim to improve daily tracking of recurrent UTIs, especially for seniors
- Could fewer antibiotics be better for older women with urinary symptoms?
- Could a probiotic plus smart antibiotic use end the cycle of recurrent UTIs in children?
- Scientists create first tools to measure recurrent UTI burden
- Simple sugar may shield catheter users from painful infections
- Can good bacteria beat bladder infections? new study investigates